DataMeds AI, Inc.

DataMeds AI, Inc. (WGRX) priced its initial public offering on Feb 21, 2025 at $4.50 per share, within its $4.50–$5.50 range, raising $4M, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $233.7M. Craft Capital was lead-left underwriter, joined by D. Boral Capital. Dykema Gossett advised the company and Sichenzia Ross Ference Carmel advised the underwriters.

At its 2025 IPO, Wellgistics Health (now DataMeds AI) was a holding company for pharmaceutical and healthcare services businesses, including a pharmacy, a technology division for hub and clinical services, and Wellgistics LLC, a licensed wholesaler supplying over 4,000 independent pharmacies in the United States.

Status

IPO

Ticker

WGRX

Exchange

Nasdaq Capital Market

Priced

Feb 21, 2025

IPO price

$4.50

Price range

$4.50–$5.50

Raised

$4M

Market cap at IPO price

$233.7M

First filed

Jul 22, 2024

Underwriters

Craft Capital and D. Boral Capital

Company counsel

Dykema Gossett

Underwriters' counsel

Sichenzia Ross Ference Carmel

Sector

Healthcare

Country / state

FL

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.